• Publications
  • Influence
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
Objective: To determine the prevalence of systemic sclerosis associated pulmonary arterial hypertension (SScPAH), evaluate outcome, and identify predictors of mortality in a large patient cohort.Expand
  • 687
  • 24
  • PDF
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Objectives To determine the causes and predictors of mortality in systemic sclerosis (SSc). Methods Patients with SSc (n=5860) fulfilling the American College of Rheumatology criteria andExpand
  • 733
  • 20
  • PDF
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
OBJECTIVE To compare fluoxetine, a selective serotonin reuptake inhibitor, with nifedipine as treatment for primary or secondary Raynaud's phenomenon. METHODS Twenty-six patients with primary andExpand
  • 208
  • 7
  • PDF
Toxicity profile of methotrexate in rheumatoid arthritis. A preliminary survey.
A number of patients with rheumatoid arthritis attending the Rheumatology Clinic at St Luke's Hospital are currently receiving the drug methotrexate as a second line disease-modifying agent. A surveyExpand
  • 12
  • 1
Paget's disease of bone in Malta. A preliminary survey.
We present the results of a preliminary survey carried out on 46 patients with Paget's disease of bone in Malta, 40 of whom were seen at a general medical outpatient clinic and a further 6 at aExpand
  • 4
  • 1
Paget’s Disease of Bone in Malta
We present the results of a preliminary survey carried out on 46 patients with Paget’s disease of bone in Malta, 40 of whom were seen at a general medical outpatient clinic and a further 6 at aExpand
  • 5
  • 1
256. Assessing the Awareness of Rheumatoid Arthritis Patients on the Occurrence of Adverse Drug Reactions Caused by Methotrexate
Background: Many people living with Inflammatory Arthritis at some point, will experience problems with their feet, which can vary dramatically, including musculoskeletal symptoms, stiffness,Expand
  • 1
  • 1
THU0490-HPR Development of medication assessment tools specific for rheumatoid arthritis
Background Medication assessment tools,first introduced in heart failure management, are evidence-based instruments intended for the evaluation of prescribing trends and monitoring of adherence toExpand
  • 1
  • 1
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
Systemic sclerosis (SSc) is a heterogeneous connective tissue disease that is typically subdivided into limited cutaneous SSc (lcSSc) and diffuse cutaneous SSc (dcSSc) depending on the extent of skinExpand
  • 18
  • PDF
Raynaud’s Phenomenon Caused by Giant Cell Arteritis
Giant cell arteritis, a systemic vasculitis that preferentially targets large and medium-sized arteries, can produce a wide variety of clinical features which may be classified into 2 groups: A)Expand
  • 6
...
1
2
3
...